rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2000-2-7
|
pubmed:abstractText |
Interferon (IFN) has been used in the treatment of patients with chronic hepatitis B virus (HBV) infection. Nonetheless, the changes in serum HBV DNA titer during IFN treatment and the effect of these changes on the therapeutic results have not been well studied.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0578-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10645044-Adult,
pubmed-meshheading:10645044-Alanine Transaminase,
pubmed-meshheading:10645044-Antiviral Agents,
pubmed-meshheading:10645044-DNA, Viral,
pubmed-meshheading:10645044-Female,
pubmed-meshheading:10645044-Hepatitis B, Chronic,
pubmed-meshheading:10645044-Humans,
pubmed-meshheading:10645044-Interferon-alpha,
pubmed-meshheading:10645044-Male,
pubmed-meshheading:10645044-Recombinant Proteins
|
pubmed:year |
2000
|
pubmed:articleTitle |
Clinical significance of changes in serum hepatitis B virus DNA titer in patients with chronic hepatitis B treated with interferon.
|
pubmed:affiliation |
Department of Medicine, Taipei Veterans General Hospital, Taiwan, ROC.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|